HealthSouth Corp (HLS) Given Average Recommendation of “Hold” by Analysts
HealthSouth Corp (NYSE:HLS) has earned an average recommendation of “Hold” from the twelve ratings firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $51.17.
A number of analysts have commented on HLS shares. Mizuho upgraded shares of HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 price target on the stock in a research report on Thursday, November 2nd. Piper Jaffray Companies reissued a “hold” rating and issued a $50.00 target price on shares of HealthSouth in a research report on Thursday, August 3rd. Zacks Investment Research downgraded shares of HealthSouth from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Robert W. Baird reiterated a “buy” rating and issued a $55.00 price target on shares of HealthSouth in a research report on Monday, October 9th. Finally, ValuEngine downgraded shares of HealthSouth from a “buy” rating to a “hold” rating in a research report on Friday, September 1st.
In other news, Director Yvonne M. Curl purchased 1,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were acquired at an average price of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the acquisition, the director now directly owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by insiders.
Shares of HealthSouth (HLS) traded up $0.64 during trading hours on Friday, reaching $49.95. 1,185,600 shares of the company’s stock were exchanged, compared to its average volume of 906,881. HealthSouth has a 12-month low of $38.24 and a 12-month high of $50.15. The company has a market cap of $4,762.17, a price-to-earnings ratio of 17.36, a P/E/G ratio of 1.78 and a beta of 0.52. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89.
HealthSouth (NYSE:HLS) last issued its earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. HealthSouth had a net margin of 6.69% and a return on equity of 22.81%. The business had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. During the same quarter last year, the firm posted $0.65 EPS. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. analysts expect that HealthSouth will post 2.72 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.00%. HealthSouth’s dividend payout ratio is currently 36.36%.
HealthSouth Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with MarketBeat.com's FREE daily email newsletter.